Literature DB >> 6201142

Patterns of Refsum's disease. Phytanic acid oxidase deficiency.

A Poulos, A C Pollard, J D Mitchell, G Wise, G Mortimer.   

Abstract

Four children each exhibiting a profound deficiency of phytanic acid oxidase activity in cultured skin fibroblasts but with very different phenotypes, are described. A consistently raised plasma phytanic acid value, generally considered to be pathognomonic for Refsum's disease (phytanic acid oxidase deficiency), was observed in three of these children but not in the fourth, who also showed no evidence of accumulation of phytanic acid in liver or fat biopsies. Our data suggest that the clinical diagnosis of Refsum's disease in children is more difficult because the full spectrum of clinical features usually observed in adults with the disorder is not always present. Moreover, a failure to detect a raised plasma phytanic acid value may not necessarily indicate normal fibroblast phytanic acid oxidase activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201142      PMCID: PMC1628542          DOI: 10.1136/adc.59.3.222

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  The quantitation of plasma phytanic acid by mass fragmentography.

Authors:  G Phillipou; A Poulos
Journal:  Clin Chim Acta       Date:  1976-11-01       Impact factor: 3.786

Review 2.  Refsum's disease (heredopathia atactica polyneuritiformis). An inborn error of lipid metabolism with storage of 3,7,11,15 tetramethyl hexadecanoic acid. A review of the clinical findings.

Authors:  R Richterich; H Moser; E Rossi
Journal:  Humangenetik       Date:  1965

3.  Refsum's disease (heredopathia atactica polyneuritiformis). An inborn error of lipid metabolism with storage of 3,7,11,15 tetramethyl hexadecanoic acid formal genetics.

Authors:  R Richterich; S Rosin; E Rossi
Journal:  Humangenetik       Date:  1965

4.  Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes.

Authors:  J H Herndon; D Steinberg; B W Uhlendorf
Journal:  N Engl J Med       Date:  1969-11-06       Impact factor: 91.245

5.  Studies on the alpha oxidation of phytanic acid by rat liver mitochondria.

Authors:  S C Tsai; J Avigan; D Steinberg
Journal:  J Biol Chem       Date:  1969-05-25       Impact factor: 5.157

6.  Refsum's disease: nature of the enzyme defect.

Authors:  D Steinberg; J H Herndon; B W Uhlendorf; C E Mize; J Avigan; G W Milne
Journal:  Science       Date:  1967-06-30       Impact factor: 47.728

7.  Studies on the metabolic error in Refsum's disease.

Authors:  D Steinberg; C E Mize; J Avigan; H M Fales; L Eldjarn; K Try; O Stokke; S Refsum
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

8.  Diagnosis of Refsum's disease using [1-14C]phytanic acid as substrate.

Authors:  A Poulos
Journal:  Clin Genet       Date:  1981-10       Impact factor: 4.438

9.  Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.

Authors:  A Masters-Thomas; J Bailes; J D Billimoria; M E Clemens; F B Gibberd; N G Page
Journal:  J Hum Nutr       Date:  1980-08

10.  Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.

Authors:  F B Gibberd; J D Billimoria; N G Page; S Retsas
Journal:  Lancet       Date:  1979-03-17       Impact factor: 79.321

View more
  18 in total

1.  Impaired plasmalogen metabolism in infantile Refsum's disease.

Authors:  B T Poll-Thé; H Ogier; J M Saudubray; R B Schutgens; R J Wanders; H van den Bosch; G Schrakamp
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

Review 2.  Metabolic pigmentary retinopathies: diagnosis and therapeutic attempts.

Authors:  B T Poll-The; T Billette de Villemeur; M Abitbol; J L Dufier; J M Saudubray
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

3.  Liver and chorion cytochemistry.

Authors:  F Roels; B De Prest; G De Pestel
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal beta-oxidation enzyme proteins.

Authors:  R J Wanders; R B Schutgens; G Schrakamp; H van den Bosch; J M Tager; A W Schram; T Hashimoto; B T Poll-Thé; J M Saudubrau
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

5.  Neonatal adrenoleukodystrophy.

Authors:  P Aubourg; J Scotto; F Rocchiccioli; D Feldmann-Pautrat; O Robain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

6.  Partial deficiency of dihydroxyacetone phosphate acyltransferase activity in both classical and infantile Refsum's diseases.

Authors:  J T Van Crugten; B Paton; A Poulos
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

7.  A case of Refsum disease with atypical clinical picture in family members.

Authors:  R Marano; P Soliveri; B Garavaglia; A Antonelli; F Girotti
Journal:  Ital J Neurol Sci       Date:  1989-08

8.  The significance of plasma phytanic acid levels in adults.

Authors:  T C Britton; F B Gibberd; M E Clemens; J D Billimoria; M C Sidey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

9.  Polarizing inclusions in some organs of children with congenital peroxisomal diseases (Zellweger's, Refsum's, chondrodysplasia punctata (rhizomelic form), X-linked adrenoleukodystrophy).

Authors:  I Kerckaert; K P Dingemans; H S Heymans; J Vamecq; F Roels
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 10.  Peroxisomal disorders: a newly recognised group of genetic diseases.

Authors:  R B Schutgens; H S Heymans; R J Wanders; H van den Bosch; J M Tager
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.